Head of Site for Ipsen's US manufacturing facility, accountable for the manufacture of a liposomal oncology product. Scope covers all site activities ( Production, Quality Operations, Manufacturing Science & Technology, Supply Chain, Logistics & Warehouse, Engineering, EHS and Operational Excellence). Member of Ipsen's Global Leadership Team, North America Steering Committee and Global Manufacturing Leadership Team.

Accountable for the management of Ipsen's external manufacturing network (CDMO's/Licensing Partners) to ensure delivery of Ipsen's speciality care products. End to end management of Product supply including managing teams responsible for the Quality Assurance/Control, CMC Regulatory, Technical and contract management. Setting and delivering the strategy for external manufacturing.API manufacture, Drug Substance Manufacture, Drug product and secondary Packaging of small and large molecules, sterile injectables and oral solid dose products.Member of the Global Supply Chain Leadership Team, the Global Manufacturing Leadership Team and UK Global Hub Leadership Committee.

Accountable for management of contracts and relationships with Ipsens outsourcing partners responsible for the manufacture of all Ipsens speciality care products. Member of Ipsen's External Manufacturing Leadership Team

Leadership of a key Ipsen Program spanning R&D, Technical and Commercial operations to re-supply an orphan drug after a 12m stock out. Management of finite stock whilst managing the transfer of the Active Pharmaceutical Ingredient. Risk management, strategy development and reporting progress to Ipsen Board.

Establishment of a CMC Project Management function, creation of the process, tools and product road maps. Accountable for the management of a team of project managers responsible for the delivery of new products from Phase II Clinical material to commercial product and lifecycle development.

Responsible for facility design, equipment selection and process definition of a new £41.5M sterile vial and lyophilisation facility using isolators and disposable technology. Project management of the performance qualification stage, management of contracts and capital budget to £5.36M, reporting of project KPI's to Executive level.

Responsible for the manufacture of a sterile lyophilised biologic, process operators and dedicated facility. Ensured cGMP, EHS compliance and member of the Change Control Committee. Successful implementation of a shift system to accommodate sales growth and reliance on overtime.

Project manager for the manufacture of Phase III clinical trial material. Transfer of a key strategic Oncology drug product to a CMO ensuring the process validation complied with FDA and EMA requirements.

Responsible for technical transfer of 5 oral liquid products within Aventis sites. Process qualification of an aseptic vial filling line for FDA approved products. Day to day supervision and training of scientists.

Technical support to the Sterile & Oncology manufacturing, trouble shooting, GMP documentation and process validation.

Responsible for qualification and validation of equipment and processes for sterile, solid dose and ointment/creams products.

Industrial placement year implementing process improvements in the oral liquid and solid dose manufacturing and packaging department.